Medicare-insured cancer and multiple sclerosis patients expect drug prices to drop new Inflation Reduction Law.
Jackie Trapp has terminal blood cancer and is taking a chemotherapy drug that cost more over $240,000 last year.
Even with Medicare Health Plan, Muskego, Wisconsin, the woman said she was charged $21,740. in out-of- pocket expenses last year for Revlimid. Stash she and her husband built decreased, and now the couple “lives on in edge”.